Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-31

Clinical Trial Update: Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lutein for retinitis pigmentosa patients receiving Vitamin A has completed, with results posted on 2014-01-31.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lutein (lutein)
  • Vitamin A (retinol)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Retinitis Pigmentosa | Phase 3 | Status: COMPLETED | Results posted: 2014-01-31